Heron Therapeutics (AXD2.STU) Q1 2026 Earnings

26FebConfirmed
Q1 2026
-0.02
0.32
0.65
0.98

Details

Expected EPS
-0.0169464
Actual EPS
-0.0169464
Surprise EPS
0
Surprise Percent
+0%

Description

Heron Therapeutics (AXD2.STU) has reported earnings of -0.0169464 per share for Q1 2026.

0 Comments

Share your thoughts